STAAR Surgical Company announced another milestone achieved on its U.S. Highway 93 go-to-market program ? a strategic agreement with IQ Laser Vision, a leader in providing clear vision to clients with locations across California and Texas, and a top EVO ICL practice in North America. IQ Laser Vision will make EVO ICL lenses a primary option for patients seeking surgical vision correction within the range of -3D to -20D, as part of its comprehensive refractive offering.

IQ Laser Vision intends to nearly double its volume in EVO ICLs over the course of the next 12 months. To support the transition and ramp up, STAAR Surgical and IQ Laser Vision will collaborate on marketing, education, practice development and clinical support activities to further elevate awareness of EVO ICL and substantially increase the availability of the lenses to all qualified patients across the IQ Laser Vision Family of Practices, which includes Scott Hyver Visioncare, Ellis Eye, and Mattioli Vision Professionals. Corneal laser-based refractive procedures, like LASIK and SMILE, work by removing corneal tissue to thin and reshape the cornea to correct a patient?s vision.

EVO ICL is a lens-based refractive procedure, which works by implanting a lens in the eye to correct a patient?s vision while preserving the cornea. Both lens and laser-based methods are safe and effective and have their place in a comprehensive refractive offering. EVO delivers excellent visual results across a broad range of correction with built-in UV protection and proven long-term stability.

Further, EVO is a reversible lens implant, allowing surgeons to future-proof a patient?s eyes if age-related vision correction is needed down the road.